| Z_SCORE |
|---|
| 2.91 |
| -0.56 |
| 0.61 |
| 2.15 |
| 0.54 |
| -0.32 |
| 1.12 |
| -0.07 |
| 0.61 |
| 1.55 |
| -0.77 |
| -0.76 |
| -2.08 |
| 0.67 |
| -0.35 |
| 0.17 |
| -1.42 |
| -0.64 |
| -5.35 |
| 1.42 |
| Concentration uM | Data readout |
|---|---|
| 33 | 55 |
| 33 | 63 |
| 33 | 65 |
| 33 | 63 |
| 33 | 61 |
| 33 | 62 |
| 33 | 61 |
| 33 | 58 |
| 33 | 71 |
| 33 | 61 |
| 33 | 64 |
| 33 | 83 |
| 33 | 158 |
| 33 | 84 |
| 33 | 104 |
| 33 | 60 |
| 33 | 62 |
| 33 | 59 |
| 33 | 58 |
| 33 | 59 |
| EXPID | PREFIX | CONCENTRATION_UNIT | CONCENTRATION | PANELNBR | CELLNBR | PANELNAME | CELLNAME | PANELCODE | M_GIPRCNT | N_GIPRCNT | STDDEV_GIPRCNT | EXP_COUNT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 88.231 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 87.1119 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 14.4371 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 89.7113 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 97.2463 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 90.0129 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 85.7031 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 30.8539 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 14.2896 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 85.8526 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 83.1036 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 84.2194 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 89.3237 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 85.6034 | 1 | 0 | 1 |
| 2106OS49 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 89.6643 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 91.2503 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 94.8714 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 93.7372 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 112.6132 | 1 | 0 | 1 |
| 2106OS52 | S | M | 1.0E-5 | 5 | 1 | Breast Cancer | MCF7 | BRE | 73.375 | 1 | 0 | 1 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 5.3 | IC50 | = | 5300 | nM | |
| 1.3 | IC50 | = | 1300 | nM | |
| 4 | IC50 | = | 4000 | nM | |
| 300 | IC50 | > | 300000 | nM | Outside typical range |
| 0.5 | IC50 | = | 500 | nM |
| Z_SCORE |
|---|
| 0.28 |
| -0.54 |
| -0.02 |
| 0.22 |
| 0.37 |
| -0.81 |
| -0.26 |
| -0.14 |
| -0.61 |
| -0.44 |
| 0.29 |
| 0.22 |
| -0.12 |
| -0.13 |
| 0.95 |
| -0.29 |
| -0.37 |
| 0.17 |
| -0.64 |
| -0.78 |
| Standard Type | Activity Comment |
|---|---|
| Activity | Active |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 4.2 | IC50 | = | 4200 | nM |
| 5.9 | Ki | = | 5900 | nM |
| 3 | IC50 | = | 3000 | nM |
| 50 | IC50 | > | 50000 | nM |
| 9 | IC50 | = | 9000 | nM |
| Activity at 15 uM | Phenotype |
|---|---|
| -3.1 | |
| 4.2 | |
| -4.8 | |
| -0.6 | |
| -3.9 | |
| -6 | |
| 75.3 | Inhibitor |
| -10.3 | |
| -7 | |
| -2 | |
| -3.8 | |
| 17.6 | |
| -4.8 | |
| -4.1 | |
| -7.8 | |
| -7.5 | |
| 15.2 | |
| 7.8 | |
| -2.5 | |
| -13.4 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Ratio IC50 | = | 2.2 |
| Ratio IC50 | = | 80 |
| Ratio IC50 | = | 133 |
| Ratio IC50 | = | 33.3 |